GlassScriptPhysician profile
Abhinav Singla
NPI 1659300796
$115,390.43
in general payments reported to CMS, 2019-2025
79 companies · $6,843 in 2025
The $6,843 reported for 2025 was more than what 94% of Addiction Medicine (Internal Medicine) providers received nationally (typical 2025 total: $124).
See the full distribution for Addiction Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $26K · 2021: $28K · 2022: $12K · 2023: $14K · 2024: $15K · 2025: $6,843.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $24K · Food and Beverage: $11K · Education: $217.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $24,015.00 |
| Food and Beverage | $11,390.61 |
| Education | $216.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $57,305.22 | 2019-2025 | Vraylar, Ubrelvy, Qulipta |
| Allergan, INC. | $37,209.67 | 2019-2021 | |
| Novo Nordisk INC | $1,552.69 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Otsuka America Pharmaceutical, INC. | $1,461.09 | 2019-2025 | Rexulti |
| Astrazeneca Pharmaceuticals LP | $1,393.71 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Lilly USA, LLC | $1,356.18 | 2019-2025 | Mounjaro, Emgality, Jardiance |
| Teva Pharmaceuticals USA, INC. | $1,241.18 | 2019-2025 | Austedo Xr, Austedo Xr, Austedo |
| Nestle Healthcare Nutrition INC. | $1,208.81 | 2020-2023 | |
| Pfizer INC. | $985.29 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $885.50 | 2019-2025 | Relistor, Xifaxan |
| Boehringer Ingelheim Pharmaceuticals, INC. | $645.37 | 2019-2024 | Jardiance, Synjardy, Tradjenta |
| Aimmune Therapeutics, INC. | $621.51 | 2024-2025 | Zenpep |
| Glaxosmithkline, LLC. | $614.87 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Axsome Therapeutics, INC. | $523.49 | 2023-2025 | Symbravo, Auvelity, Sunosi |
| Takeda Pharmaceuticals U.S.A., INC. | $477.80 | 2019-2025 | Trintellix |
Show all 79 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $460.91 | 2019-2024 | Repatha, Otezla |
| Orexo US, INC. | $416.38 | 2019-2025 | Zubsolv |
| Upsher-Smith Laboratories LLC | $334.80 | 2019-2022 | |
| Lundbeck LLC | $309.70 | 2020-2025 | Rexulti |
| Collegium Pharmaceutical, INC. | $302.17 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $274.37 | 2019-2022 | |
| Harmony Biosciences LLC | $262.54 | 2023-2025 | Wakix |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $254.68 | 2023-2025 | Caplyta |
| Jazz Pharmaceuticals INC. | $244.28 | 2019-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $240.42 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $234.76 | 2022-2024 | Livalo, Seglentis |
| Phathom Pharmaceuticals, INC. | $222.47 | 2024-2025 | Voquezna |
| Currax Pharmaceuticals LLC | $220.11 | 2019-2025 | Contrave, Onzetra Xsail, Nexlizet |
| Alkermes, INC. | $196.44 | 2019-2025 | Aristada, Lybalvi |
| Almatica Pharma LLC | $189.95 | 2020-2024 | Loreev Xr |
| Antares Pharma, INC. | $177.37 | 2019-2025 | Xyosted, Nocdurna, Tlando |
| E.R. Squibb & Sons, L.L.C. | $175.04 | 2020-2024 | Eliquis |
| Amarin Pharma, INC. | $166.81 | 2019-2022 | |
| Inspire Medical Systems, INC. | $143.45 | 2025 | Inspire |
| Braeburn INC. | $139.79 | 2023-2025 | Brixadi |
| Bayer Healthcare Pharmaceuticals INC. | $139.58 | 2022-2024 | |
| Sk Life Science, INC. | $137.24 | 2022-2024 | Xcopri |
| Merck Sharp & Dohme LLC | $133.01 | 2021-2023 | Belsomra |
| Indivior INC. | $130.51 | 2019-2024 | Sublocade |
| Uswm, LLC | $123.28 | 2021-2023 | Zimhi, Lucemyra |
| Sanofi-Aventis U.S. LLC | $115.39 | 2019-2021 | |
| Bausch Health US, LLC | $111.65 | 2019-2022 | |
| Scilex Pharmaceuticals INC. | $110.40 | 2019-2025 | |
| Amneal Pharmaceuticals LLC | $108.30 | 2019-2022 | |
| Vivus LLC | $102.46 | 2019-2025 | Pancreaze |
| Novartis Pharmaceuticals Corporation | $102.39 | 2022-2023 | |
| Ibsa Pharma INC. | $100.81 | 2021-2022 | |
| Biodelivery Sciences International, INC. | $100.16 | 2019-2021 | |
| Redhill Biopharma INC. | $94.36 | 2020-2021 | |
| Vanda Pharmaceuticals INC. | $89.64 | 2024-2025 | Fanapt |
| Horizon Therapeutics Plc | $73.10 | 2019-2021 | |
| Exact Sciences Corporation | $70.88 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Idorsia Pharmaceuticals US INC | $68.48 | 2023-2024 | Quviviq |
| Arbor Pharmaceuticals, INC. | $65.25 | 2019-2021 | |
| Corcept Therapeutics | $63.90 | 2019 | |
| Eisai INC. | $63.84 | 2019-2022 | |
| Astellas Pharma US INC | $60.89 | 2019-2021 | |
| Xeris Pharmaceuticals, INC. | $58.72 | 2021-2022 | |
| Impel Pharmaceuticals LLC | $56.53 | 2024-2025 | Trudhesa |
| Ethicon US, LLC | $52.86 | 2019-2020 | |
| Hikma Pharmaceuticals USA | $49.33 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $45.57 | 2019 | |
| Neuronetics, INC. | $44.89 | 2019 | |
| Impel Pharmaceuticals INC. | $44.21 | 2023 | Trudhesa |
| Mdd US Operations, LLC | $43.40 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $42.77 | 2021 | |
| Halozyme INC | $40.10 | 2023 | |
| Abbott Laboratories | $39.51 | 2023-2025 | Freestyle Libre 3 |
| Clarus Therapeutics INC. | $36.15 | 2021 | |
| Adlon Therapeutics L.P. | $32.27 | 2020-2021 | |
| Dexcom, INC. | $30.45 | 2024 | Dexcom G6 Transmitter |
| Philips North America LLC | $29.99 | 2023 | |
| Boston Scientific Corporation | $24.66 | 2024 | Watchman Flx |
| Kaleo, INC. | $21.13 | 2019 | |
| Shire North American Group INC | $19.96 | 2019 | |
| Esperion Therapeutics, INC. | $19.66 | 2022 | |
| Azurity Pharmaceuticals, INC. | $17.06 | 2023 | Horizant |
| Shionogi INC | $14.39 | 2019 | |
| Assertio Therapeutics, INC. | $12.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abhinav Singla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.